Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the…
SHENZHEN, China, Feb. 6, 2026 /PRNewswire/ -- Following its recognition as a CES 2026 Innovation Award Honoree, the iGarden M1…
DAVOS, Switzerland and MUMBAI, India, Feb. 6, 2026 /PRNewswire/ -- ACG Packaging Materials today announced that its Shirwal facility has…
With 98.9% success rate and 77 AI agents built autonomously for brands across 8 regions in early access, Nexus by Yellow.ai…
DPTX3186, a first-in-class beta-catenin condensate modulator, received Orphan Drug Designation and Fast Track Designation from FDAClinical entry validates condensate modulator…
QINGDAO, China, Feb. 3, 2026 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, announced that the…
Initiation of trial marks first-in-human milestone for Neomorph’s novel molecular glue degrader platform February 03, 2026 13:08 ET | Source:…
February 03, 2026 13:06 ET | Source: Restem Initiation of the IIMPACT study follows promising Phase 1 results where Restem-L…
GURGAON, India, Feb. 2, 2026 /PRNewswire/ -- For young India, experiences today are about belonging, shared energy, and being part…
SINGAPORE, Feb. 2, 2026 /PRNewswire/ -- Gstar announced that its 183N, 210RN series photovoltaic (PV) modules have achieved certification under…